186 related articles for article (PubMed ID: 16112273)
41. [Interleukin 12 (IL-12) and its receptor].
Szeliga J; Gościcka T
Postepy Hig Med Dosw; 2002; 56(2):185-99. PubMed ID: 12107962
[TBL] [Abstract][Full Text] [Related]
42. Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease.
Mentink-Kane MM; Wynn TA
Immunol Rev; 2004 Dec; 202():191-202. PubMed ID: 15546394
[TBL] [Abstract][Full Text] [Related]
43. Generation of highly stable IL-18 based on a ligand-receptor complex structure.
Yamamoto Y; Kato Z; Matsukuma E; Li A; Omoya K; Hashimoto K; Ohnishi H; Kondo N
Biochem Biophys Res Commun; 2004 Apr; 317(1):181-6. PubMed ID: 15047165
[TBL] [Abstract][Full Text] [Related]
44. [Interleukin-18 and new drugs. Protective effect against tumor growth and infections].
Wollheim FA
Lakartidningen; 2000 Oct; 97(41):4604. PubMed ID: 11107747
[TBL] [Abstract][Full Text] [Related]
45. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.
Bleicher L; de Moura PR; Watanabe L; Colau D; Dumoutier L; Renauld JC; Polikarpov I
FEBS Lett; 2008 Sep; 582(20):2985-92. PubMed ID: 18675809
[TBL] [Abstract][Full Text] [Related]
46. Recruitment pharmacophore for interleukin 5 receptor alpha antagonism.
Bhattacharya M; Pillalamari U; Sarkhel S; Ishino T; Urbina C; Jameson B; Chaiken I
Biopolymers; 2007; 88(1):83-93. PubMed ID: 17041908
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
48. Creation of a biologically active interleukin-5 monomer.
Dickason RR; Huston DP
Nature; 1996 Feb; 379(6566):652-5. PubMed ID: 8628400
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-22 and its crystal structure.
Nagem RA; Ferreira Júnior JR; Dumoutier L; Renauld JC; Polikarpov I
Vitam Horm; 2006; 74():77-103. PubMed ID: 17027512
[TBL] [Abstract][Full Text] [Related]
50. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.
Graber P; Proudfoot AE; Talabot F; Bernard A; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Wells TN
J Biol Chem; 1995 Jun; 270(26):15762-9. PubMed ID: 7797578
[TBL] [Abstract][Full Text] [Related]
51. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
52. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
[TBL] [Abstract][Full Text] [Related]
53. Interactions among the components of the interleukin-10 receptor complex.
Krause CD; Mei E; Mirochnitchenko O; Lavnikova N; Xie J; Jia Y; Hochstrasser RM; Pestka S
Biochem Biophys Res Commun; 2006 Feb; 340(2):377-85. PubMed ID: 16364239
[TBL] [Abstract][Full Text] [Related]
54. Human anti-human IL-18 antibody recognizing the IL-18-binding site 3 with IL-18 signaling blocking activity.
Hamasaki T; Hashiguchi S; Ito Y; Kato Z; Nakanishi K; Nakashima T; Sugimura K
J Biochem; 2005 Oct; 138(4):433-42. PubMed ID: 16272137
[TBL] [Abstract][Full Text] [Related]
55. Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions.
Raimundo BC; Oslob JD; Braisted AC; Hyde J; McDowell RS; Randal M; Waal ND; Wilkinson J; Yu CH; Arkin MR
J Med Chem; 2004 Jun; 47(12):3111-30. PubMed ID: 15163192
[TBL] [Abstract][Full Text] [Related]
56. Biology of IL-5 in health and disease.
Lalani T; Simmons RK; Ahmed AR
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):317-32; quiz 332-3. PubMed ID: 10227331
[TBL] [Abstract][Full Text] [Related]
57. Identification of core functional region of murine IL-4 using peptide phage display and molecular modeling.
Yao G; Chen W; Luo H; Jiang Q; Xia Z; Zang L; Zuo J; Wei X; Chen Z; Shen X; Dong C; Sun B
Int Immunol; 2006 Jan; 18(1):19-29. PubMed ID: 16361318
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response.
Ip WK; Wong CK; Li ML; Li PW; Cheung PF; Lam CW
Immunology; 2007 Dec; 122(4):532-41. PubMed ID: 17627770
[TBL] [Abstract][Full Text] [Related]
59. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
60. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
